Literature DB >> 27616746

Staging and classification criteria for middle ear cholesteatoma proposed by the Japan Otological Society.

Tetsuya Tono1, Masafumi Sakagami2, Hiromi Kojima3, Yutaka Yamamoto3, Keiji Matsuda4, Manabu Komori5, Naohito Hato6, Yuka Morita7, Sho Hashimoto8.   

Abstract

In order to provide a basis for meaningful exchange of information among those treating cholesteatoma, the Committee on Nomenclature of the Japan Otological Society (JOS) was appointed in 2004 to create a cholesteatoma staging system as simple as possible to use in clinical practice in Japan. Following the announcement of preliminary criteria for the staging of pars flaccida (attic) cholesteatoma in 2008, we proposed the 2010 JOS staging system for two major types of retraction pocket cholesteatoma, pars flaccida and pars tensa cholesteatoma. Since then, the JOS staging system has been widely used in clinical studies of cholesteatoma in Japan, allowing standardization in reporting of surgical outcomes based on the respective stages of cholesteatoma. We have recently expanded the range of cholesteatoma by adding cholesteatoma secondary to a tensa perforation and congenital cholesteatoma as the 2015 JOS staging system for middle ear cholesteatoma. Although further revisions may be required for universal acceptance of these criteria, we hope our staging system will open the way for international consensus on staging and classification of middle ear cholesteatoma in the near future.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Classification; Middle ear cholesteatoma; Staging

Mesh:

Year:  2016        PMID: 27616746     DOI: 10.1016/j.anl.2016.06.012

Source DB:  PubMed          Journal:  Auris Nasus Larynx        ISSN: 0385-8146            Impact factor:   1.863


  13 in total

1.  Correlation between Surgical Outcome and Stage of Acquired Middle Ear Cholesteatoma: Revalidation of the EAONO/JOS Staging System.

Authors:  Fazıl Necdet Ardıç; Erdem Mengi; Funda Tümkaya; Cüneyt Orhan Kara; Ferda Bir
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

2.  Factors Affecting Postoperative Hearing Results in Type IV Tympanoplasty: Preliminary Study of the Influence of External Auditory Canal Packing Material.

Authors:  Hiroaki Yazama; Tasuku Watanabe; Kazunori Fujiwara; Hiromi Takeuchi
Journal:  Yonago Acta Med       Date:  2020-11-24       Impact factor: 1.641

3.  Preoperative prediction for mastoid extension of middle ear cholesteatoma using temporal subtraction serial HRCT studies.

Authors:  Akira Baba; Ryo Kurokawa; Mariko Kurokawa; Yoshiaki Ota; Satoshi Matsushima; Takeshi Fukuda; Hideomi Yamauchi; Rui Kano; Tomokazu Shoji; Sho Kurihara; Takara Nakazawa; Yutaka Yamamoto; Hiromi Kojima; Ashok Srinivasan; Hiroya Ojiri
Journal:  Eur Radiol       Date:  2022-01-11       Impact factor: 5.315

4.  Investigation of the Serum Level of Vitamin D in Patients with Ear Cholesteatoma.

Authors:  Fatemeh Fanimolky; Maryam Amizadeh
Journal:  Iran J Otorhinolaryngol       Date:  2022-03

5.  Cholesteatoma Classification: Review of Literature and Proposed Indian Classification System-TAMPFIC.

Authors:  M B Bharathi; Pranshu Mehta; Kavya Sivapuram; D Sandhya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-09-29

6.  Retrograde mastoidectomy with canal wall reconstruction versus intact canal wall tympanomastoidectomy for cholesteatoma with minimal mastoid extension.

Authors:  Masaomi Motegi; Yutaka Yamamoto; Taisuke Akutsu; Takahiro Nakajima; Masahiro Takahashi; Sayaka Sampei; Kazuhisa Yamamoto; Tomokatsu Udagawa; Yuika Sakurai; Hiromi Kojima
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-03-29       Impact factor: 3.236

7.  Short-Term Hearing Prognosis of Ossiculoplasty in Pars Flaccida Cholesteatoma Using the EAONO/JOS Staging System.

Authors:  Atsushi Fukuda; Shinya Morita; Yuji Nakamaru; Kimiko Hoshino; Keishi Fujiwara; Akihiro Homma
Journal:  J Int Adv Otol       Date:  2019-04       Impact factor: 1.017

8.  The significance of selected prognostic factors in pediatric tympanoplasty.

Authors:  Aleksander Zwierz; Karolina Haber; Anna Sinkiewicz; Paulina Kalińczak-Górna; Justyna Tyra; Józef Mierzwiński
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-11-27       Impact factor: 2.503

9.  Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma.

Authors:  Taichi Kan; Hiromi Ueda; Taishi Takahara; Yoshimasa Tsuchiya; Mayuko Kishimoto; Yasue Uchida; Tetsuya Ogawa; Wataru Ohashi; Toyonori Tsuzuki; Yasushi Fujimoto
Journal:  Biomed Res Int       Date:  2021-03-10       Impact factor: 3.411

10.  Association of CARD8 Activating Polymorphism With Bone Erosion in Cholesteatoma Patients.

Authors:  Neel Sangal; John Yan; Jessica Pryor; Marcus L Elias; Biju Joseph; Luis Ulloa; Robert W Jyung
Journal:  Laryngoscope       Date:  2020-05-12       Impact factor: 2.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.